Rivastigmine Metabolism and Pharmacokinetics

Pharmacokinetic Properties

• Rivastigmine is classified as a pseudo-irreversible or intermediate-acting cholinesterase inhibitor because its inhibition of acetylcholinesterase lasts up to 10 hours, despite the short plasma half-life 1

Clinical Implications

• No specific clinical implications are mentioned with a valid citation id.